Detalhe da pesquisa
1.
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
Am J Hematol
; 99(3): 350-359, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165016
2.
A fixed-duration, measurable residual disease-guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial.
Blood
; 137(8): 1019-1023, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33167024
3.
Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemia.
Future Oncol
; 19(5): 345-353, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815271
4.
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study.
Br J Haematol
; 193(2): 325-338, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33605445
5.
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.
N Engl J Med
; 378(25): 2399-2410, 2018 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856685
6.
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
Acta Oncol
; 60(4): 466-474, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33112687
7.
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life.
Ann Hematol
; 99(7): 1595-1604, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32417940
8.
Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide.
Ann Hematol
; 99(6): 1341-1350, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342134
9.
Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies.
Biol Blood Marrow Transplant
; 25(7): 1465-1471, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30928627
10.
Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.
Biol Blood Marrow Transplant
; 25(5): 906-911, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30481598
11.
FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemia.
Cytokine
; 120: 85-87, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31035172
12.
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study.
Ann Hematol
; 98(6): 1441-1447, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30874851
13.
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study.
Ann Hematol
; 98(6): 1435-1440, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30874850
14.
Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(1): 140-146, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27751934
15.
Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant.
Br J Haematol
; 196(5): e38-e40, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671982
16.
Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.
Br J Haematol
; 196(2): 360-362, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476803
17.
Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?
Eur J Haematol
; 99(1): 60-69, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370306
18.
Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study.
Blood
; 124(14): 2196-202, 2014 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25143487
19.
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Am J Hematol
; 91(4): 366-70, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26689746
20.
Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
Biol Blood Marrow Transplant
; 21(1): 180-4, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25175796